- A H Groll: Immunocompromised Host Section, National Cancer Institute, NIH, Bethesda, MD, USA.
Invasive mycoses have become important causes of morbidity and mortality in immunocompromised patients. New approaches for antifungal therapy are required to meet the challenges imposed by these life-threatening infections. Such approaches are being developed through identification of novel biochemical and molecular targets of pathogenic fungi.